Close Menu

Note: This article has been updated with additional information from Abbott's earnings call. 

NEW YORK — Abbott reported Wednesday that its fourth quarter diagnostics revenues rose 5 percent year over year.

For the three months ended Dec. 31, the Abbott Park, Illinois-based firm reported overall revenues of $8.31 billion, up 7 percent from $7.77 billion a year ago and beating the consensus Wall Street estimate of $8.26 billion. Organic sales, which excluded the impact of foreign exchange, grew 9 percent year over year.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A survey by Nature finds that most researchers want scientific meetings to continue virtually or with a virtual component, even after the pandemic ends.

Bloomberg reports that the B.1.351 SARS-CoV-2 viral variant could prompt the formulation of better vaccines.

Certain blood proteins may be able to distinguish COVID-19 patients who will become critically ill from those who will not, the Atlanta Journal-Constitution reports.

In Genome Biology this week: algorithm to assess regulatory features, approach to integrate multiple single-cell RNA-seq datasets, and more.